About the Cancer Proteome Session
Exploring the labyrinth of the cancer proteome stands as a cornerstone in oncological exploration, unraveling the molecular intricacies orchestrating tumorigenesis and therapeutic avenues. By delving into the complete protein repertoire within cancerous cells, scientists decode the interplay, mutations, and impact of these proteins on cellular dynamics. This profound comprehension paves the way for tailored treatments aimed at disrupting specific cancer-driving pathways. Moreover, the cancer proteome illumination unveils the heterogeneous nature of tumors, facilitating subtype categorization and bespoke therapeutic strategies. With advancements like mass spectrometry and bioinformatics, our comprehension of the cancer proteome deepens, heralding a new era of precision and personalized cancer management.
Topics Covered in Cancer Proteome
Mass Spectrometry Proteomics
Phosphoproteomics
Protein Biomarkers
Proteogenomics
Protein Interaction Networks
Proteomic Subtyping
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Proteome Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Proteome work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Proteome research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Proteome track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Proteome Conference 2027 — FAQs
What is the Cancer Proteome track at CIOC 2027?
The Cancer Proteome track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Proteome. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Proteome sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Proteome are all welcome — whether presenting or attending.
Can I present my research in the Cancer Proteome track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Proteome sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Proteome track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.